This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. 
The pediatric heart valve repair and replacement market size has grown steadily in recent years. It will grow from $3.36 billion in 2024 to $3.49 billion in 2025 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to increasing prevalence of congenital heart defects, growing awareness and early diagnosis, supportive regulatory environment, rising healthcare investments, and patient and parent advocacy.
The pediatric heart valve repair and replacement market size is expected to see steady growth in the next few years. It will grow to $3.86 billion in 2029 at a compound annual growth rate (CAGR) of 2.5%. The growth in the forecast period can be attributed to increased incidence of pediatric cardiovascular conditions, expanded access to pediatric cardiac care, growing emphasis on early intervention, rise in pediatric cardiovascular research, and global healthcare infrastructure development. Major trends in the forecast period include growing adoption of tissue-engineered heart valves, pediatric-specific device innovation, expansion of hybrid approaches, rising application of 3d printing technology, and pediatric valve-in-valve procedures.
The rising prevalence of congenital heart defects is anticipated to drive the growth of the pediatric heart valve repair and replacement market in the future. A congenital heart defect (CHD) refers to an abnormality in the heart's structure that is present at birth. Pediatric heart valve repair and replacement are utilized in treating congenital heart defects to enhance heart function, improve the overall health of the child, prevent complications, and enhance the quality of life for those affected. For example, in October 2024, reports from the Centers for Disease Control and Prevention, a US-based national public health agency, indicated that heart defects impact nearly 1% of births - approximately 40,000 infants - each year in the United States. About 1 in 4 babies with a heart defect are diagnosed with a critical heart defect. In 2023, a baby was born with a heart defect in America every 15 minutes. Therefore, the increasing incidence of congenital heart defects is expected to stimulate growth in the pediatric heart valve repair and replacement market.
Major companies within the pediatric heart valve repair and replacement industry are embracing a strategic partnership approach to deliver customized solutions that cater to the distinct requirements of pediatric cardiac care. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and success. For example, in August 2023, PolyVascular Inc., a US-based medical technology manufacturer, joined forces with CobiCure, a US-based not-for-profit organization focused on pediatric care. Through this collaboration, their aim is to advance pediatric heart valve repair by offering a tailored, non-surgical approach to address congenital heart defects in children. By eliminating the need for multiple open-heart surgeries as children outgrow traditional valves, they seek to minimize associated complications and enhance patient outcomes.
In July 2024, Edwards Lifesciences, a medical technology company based in the US, acquired Innovalve Bio Medical Ltd. for an undisclosed sum. This acquisition is intended to enhance the company’s transcatheter mitral valve replacement (TMVR) technologies to address significant unmet needs among structural heart patients and support sustainable long-term growth. Innovalve Bio Medical Ltd. is an Israel-based developer of TMVR technology and cardiac valves.
Major companies operating in the pediatric heart valve repair and replacement market report are Abbott Laboratories, Medtronic plc, Labcor Laboratórios Ltda, Boston Scientific Corporation, Bracco Group, Lepu Medical Technology (Beijing) Co. Ltd., Edwards Lifesciences Corporation, Artivion Inc., CryoLife Inc., LivaNova PLC, TTK Healthcare Limited, Braile Biomedica Ltda., Arbor Surgical Technologies Inc., Micro Interventional Devices Inc., Xeltis AG, Auto Tissue Berlin GmbH, BioStable Science and Engineering Inc., Colibri Heart Valve LLC, Valcare Medical, Symetis SA, Neovasc Inc., Aortech international Plc., On-X Life Technologies Holdings Inc., JenaValve Technology Inc., Meril Life Sciences Pvt. Ltd.
North America was the largest region in the pediatric heart valve repair and replacement market in 2024. The regions covered in the pediatric heart valve repair and replacement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pediatric heart valve repair and replacement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pediatric heart valve repair and replacement market includes revenues earned by providing services such as diagnosis and evaluation, treatment planning, medical management, surgical intervention and surgery. The market value includes the value of related goods sold by the service provider or included within the service offering. The pediatric heart valve repair and replacement market also consists of sales of biological valves, postoperative monitoring devices, sutures and repair materials, annuloplasty rings and bands, and annuloplasty rings and bands. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
Pediatric heart valve repair and replacement encompass medical procedures and technologies utilized to address heart valve issues in children, particularly targeting congenital or acquired heart valve disorders. These procedures are essential for treating conditions such as congenital heart defects, heart muscle disease, arrhythmias, and atresia.
The primary products in pediatric heart valve repair and replacement include heart valve repair, mechanical heart valves, bioprosthetic heart valves, and transcatheter aortic valve implantation (TAVI). Heart valve repair involves restoring the normal function of a malfunctioning heart valve through medical intervention. This procedure is indicated for various cardiac disorders, including congenital heart defects, heart muscle disease, atresia, arrhythmias, among others. The end-users of these products typically include hospitals, independent cardiac catheterization labs, and ambulatory surgical centers.
The pediatric heart valve repair and replacement market research report is one of a series of new reports that provides pediatric heart valve repair and replacement market statistics, including pediatric heart valve repair and replacement industry global market size, regional shares, competitors with a pediatric heart valve repair and replacement market share, detailed pediatric heart valve repair and replacement market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric heart valve repair and replacement industry. This pediatric heart valve repair and replacement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The pediatric heart valve repair and replacement market size has grown steadily in recent years. It will grow from $3.36 billion in 2024 to $3.49 billion in 2025 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to increasing prevalence of congenital heart defects, growing awareness and early diagnosis, supportive regulatory environment, rising healthcare investments, and patient and parent advocacy.
The pediatric heart valve repair and replacement market size is expected to see steady growth in the next few years. It will grow to $3.86 billion in 2029 at a compound annual growth rate (CAGR) of 2.5%. The growth in the forecast period can be attributed to increased incidence of pediatric cardiovascular conditions, expanded access to pediatric cardiac care, growing emphasis on early intervention, rise in pediatric cardiovascular research, and global healthcare infrastructure development. Major trends in the forecast period include growing adoption of tissue-engineered heart valves, pediatric-specific device innovation, expansion of hybrid approaches, rising application of 3d printing technology, and pediatric valve-in-valve procedures.
The rising prevalence of congenital heart defects is anticipated to drive the growth of the pediatric heart valve repair and replacement market in the future. A congenital heart defect (CHD) refers to an abnormality in the heart's structure that is present at birth. Pediatric heart valve repair and replacement are utilized in treating congenital heart defects to enhance heart function, improve the overall health of the child, prevent complications, and enhance the quality of life for those affected. For example, in October 2024, reports from the Centers for Disease Control and Prevention, a US-based national public health agency, indicated that heart defects impact nearly 1% of births - approximately 40,000 infants - each year in the United States. About 1 in 4 babies with a heart defect are diagnosed with a critical heart defect. In 2023, a baby was born with a heart defect in America every 15 minutes. Therefore, the increasing incidence of congenital heart defects is expected to stimulate growth in the pediatric heart valve repair and replacement market.
Major companies within the pediatric heart valve repair and replacement industry are embracing a strategic partnership approach to deliver customized solutions that cater to the distinct requirements of pediatric cardiac care. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and success. For example, in August 2023, PolyVascular Inc., a US-based medical technology manufacturer, joined forces with CobiCure, a US-based not-for-profit organization focused on pediatric care. Through this collaboration, their aim is to advance pediatric heart valve repair by offering a tailored, non-surgical approach to address congenital heart defects in children. By eliminating the need for multiple open-heart surgeries as children outgrow traditional valves, they seek to minimize associated complications and enhance patient outcomes.
In July 2024, Edwards Lifesciences, a medical technology company based in the US, acquired Innovalve Bio Medical Ltd. for an undisclosed sum. This acquisition is intended to enhance the company’s transcatheter mitral valve replacement (TMVR) technologies to address significant unmet needs among structural heart patients and support sustainable long-term growth. Innovalve Bio Medical Ltd. is an Israel-based developer of TMVR technology and cardiac valves.
Major companies operating in the pediatric heart valve repair and replacement market report are Abbott Laboratories, Medtronic plc, Labcor Laboratórios Ltda, Boston Scientific Corporation, Bracco Group, Lepu Medical Technology (Beijing) Co. Ltd., Edwards Lifesciences Corporation, Artivion Inc., CryoLife Inc., LivaNova PLC, TTK Healthcare Limited, Braile Biomedica Ltda., Arbor Surgical Technologies Inc., Micro Interventional Devices Inc., Xeltis AG, Auto Tissue Berlin GmbH, BioStable Science and Engineering Inc., Colibri Heart Valve LLC, Valcare Medical, Symetis SA, Neovasc Inc., Aortech international Plc., On-X Life Technologies Holdings Inc., JenaValve Technology Inc., Meril Life Sciences Pvt. Ltd.
North America was the largest region in the pediatric heart valve repair and replacement market in 2024. The regions covered in the pediatric heart valve repair and replacement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pediatric heart valve repair and replacement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pediatric heart valve repair and replacement market includes revenues earned by providing services such as diagnosis and evaluation, treatment planning, medical management, surgical intervention and surgery. The market value includes the value of related goods sold by the service provider or included within the service offering. The pediatric heart valve repair and replacement market also consists of sales of biological valves, postoperative monitoring devices, sutures and repair materials, annuloplasty rings and bands, and annuloplasty rings and bands. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
Pediatric heart valve repair and replacement encompass medical procedures and technologies utilized to address heart valve issues in children, particularly targeting congenital or acquired heart valve disorders. These procedures are essential for treating conditions such as congenital heart defects, heart muscle disease, arrhythmias, and atresia.
The primary products in pediatric heart valve repair and replacement include heart valve repair, mechanical heart valves, bioprosthetic heart valves, and transcatheter aortic valve implantation (TAVI). Heart valve repair involves restoring the normal function of a malfunctioning heart valve through medical intervention. This procedure is indicated for various cardiac disorders, including congenital heart defects, heart muscle disease, atresia, arrhythmias, among others. The end-users of these products typically include hospitals, independent cardiac catheterization labs, and ambulatory surgical centers.
The pediatric heart valve repair and replacement market research report is one of a series of new reports that provides pediatric heart valve repair and replacement market statistics, including pediatric heart valve repair and replacement industry global market size, regional shares, competitors with a pediatric heart valve repair and replacement market share, detailed pediatric heart valve repair and replacement market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric heart valve repair and replacement industry. This pediatric heart valve repair and replacement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Pediatric Heart Valve Repair and Replacement Market Characteristics3. Pediatric Heart Valve Repair and Replacement Market Trends and Strategies4. Pediatric Heart Valve Repair and Replacement Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Pediatric Heart Valve Repair and Replacement Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Pediatric Heart Valve Repair and Replacement Market34. Recent Developments in the Pediatric Heart Valve Repair and Replacement Market
5. Global Pediatric Heart Valve Repair and Replacement Growth Analysis and Strategic Analysis Framework
6. Pediatric Heart Valve Repair and Replacement Market Segmentation
7. Pediatric Heart Valve Repair and Replacement Market Regional and Country Analysis
8. Asia-Pacific Pediatric Heart Valve Repair and Replacement Market
9. China Pediatric Heart Valve Repair and Replacement Market
10. India Pediatric Heart Valve Repair and Replacement Market
11. Japan Pediatric Heart Valve Repair and Replacement Market
12. Australia Pediatric Heart Valve Repair and Replacement Market
13. Indonesia Pediatric Heart Valve Repair and Replacement Market
14. South Korea Pediatric Heart Valve Repair and Replacement Market
15. Western Europe Pediatric Heart Valve Repair and Replacement Market
16. UK Pediatric Heart Valve Repair and Replacement Market
17. Germany Pediatric Heart Valve Repair and Replacement Market
18. France Pediatric Heart Valve Repair and Replacement Market
19. Italy Pediatric Heart Valve Repair and Replacement Market
20. Spain Pediatric Heart Valve Repair and Replacement Market
21. Eastern Europe Pediatric Heart Valve Repair and Replacement Market
22. Russia Pediatric Heart Valve Repair and Replacement Market
23. North America Pediatric Heart Valve Repair and Replacement Market
24. USA Pediatric Heart Valve Repair and Replacement Market
25. Canada Pediatric Heart Valve Repair and Replacement Market
26. South America Pediatric Heart Valve Repair and Replacement Market
27. Brazil Pediatric Heart Valve Repair and Replacement Market
28. Middle East Pediatric Heart Valve Repair and Replacement Market
29. Africa Pediatric Heart Valve Repair and Replacement Market
30. Pediatric Heart Valve Repair and Replacement Market Competitive Landscape and Company Profiles
31. Pediatric Heart Valve Repair and Replacement Market Other Major and Innovative Companies
35. Pediatric Heart Valve Repair and Replacement Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Pediatric Heart Valve Repair And Replacement Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on pediatric heart valve repair and replacement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pediatric heart valve repair and replacement? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pediatric heart valve repair and replacement market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Heart Valve Repair; Mechanical Heart Valves; Bioprosthetic Heart Valves; Transcatheter Aortic Valve Implantation (TAVI)2) By Indication: Congenital Heart Defects; Heart Muscle Disease; Atresia; Arrhythmias; Other Cardiac Disorders
3) By End-User: Hospitals; Independent Cardiac Catheterization Labs; Ambulatory Surgical Centers
Subsegments:
1) By Heart Valve Repair: Surgical Repair Techniques; Catheter-Based Repair Techniques2) By Mechanical Heart Valves: Tilting Disc Valves; Bileaflet Valves; Other Mechanical Valves
3) By Bioprosthetic Heart Valves: Porcine Valves; Bovine Valves; Other Bioprosthetic Valves
4) By Transcatheter Aortic Valve Implantation (TAVI): Balloon-Expandable Valves; Self-Expanding Valves; Other TAVI Devices
Key Companies Mentioned: Abbott Laboratories; Medtronic plc; Labcor Laboratórios Ltda; Boston Scientific Corporation; Bracco Group
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 3.49 Billion |
| Forecasted Market Value ( USD | $ 3.86 Billion |
| Compound Annual Growth Rate | 2.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
